{
    "code": "01021012",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01021012",
    "time": "2019-06-07 03:13:50",
    "許可證字號": "衛署藥製字第021012號",
    "註銷狀態": "已註銷",
    "註銷日期": "108\/05\/14",
    "註銷理由": "自請註銷",
    "有效日期": "109\/03\/18",
    "發證日期": "69\/03\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102101200",
    "中文品名": "溫若林注射劑１公克（西華樂林）",
    "英文品名": "WINZOLIN INJECTION 1G (CEFAZOLIN) &quot;WINSTON&quot;",
    "適應症": "葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染症",
    "劑型": "240乾粉注射劑",
    "包裝": "1g(力價)\/Vial，100支以下盒裝\/vial",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "CEFAZOLIN (SODIUM)",
    "主製造廠": {
        "申請商名稱": "1217820200  溫士頓醫藥股份有限公司",
        "申請商地址": "台南市永康區鹽洲里仁愛街１１７號",
        "主製造廠": "",
        "製造廠名稱": "1217820300  溫士頓醫藥股份有限公司"
    },
    "CCC號列": "30042000319 人用醫藥製劑，含頭孢子菌類抗生素者Medicaments, containing cephalosporins, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812309510",
            "成分名稱": "CEFAZOLIN (SODIUM)",
            "含量描述": "1",
            "含量": "1.0000000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "溫若林注射劑1公克-說明書(衛署藥製字第021012號)2016.08.08-105-08-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01021012&Seq=002&Type=9"
        },
        {
            "title": "溫若林注射劑1公克-標籤(衛署藥製字第021012號)2016.08.08-105-08-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01021012&Seq=001&Type=8"
        }
    ]
}